XML 28 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Total
Beginning balance at Dec. 31, 2022 $ 17 $ 1,941,569 $ (1,453,744) $ 30,585 $ 518,427
Beginning balance (in shares) at Dec. 31, 2022 168,324,995        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   15     15
Exercise of stock options (in shares) 7,816        
Vesting of restricted stock awards and units (in shares) 4,840,738        
Vesting of performance-based stock units (in shares) 381,071        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (4,481)     (4,481)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,470,953)        
Stock-based compensation expense   21,806     21,806
Other comprehensive loss       (16,798) (16,798)
Net income (loss)     (66,206)   (66,206)
Ending balance at Dec. 31, 2023 $ 17 1,958,909 (1,519,950) 13,787 452,763
Ending balance (in shares) at Dec. 31, 2023 172,083,667        
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   21     21
Exercise of stock options (in shares) 11,285        
Vesting of restricted stock awards and units $ 1       1
Vesting of restricted stock awards and units (in shares) 4,653,037        
Vesting of performance-based stock units (in shares) 298,586        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (4,308)     (4,308)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,447,325)        
Stock-based compensation expense   16,086     16,086
Other comprehensive loss       (5,707) (5,707)
Net income (loss)     (54,235)   (54,235)
Ending balance at Dec. 31, 2024 $ 18 1,970,708 (1,574,185) 8,080 $ 404,621
Ending balance (in shares) at Dec. 31, 2024 175,599,250       175,599,250
Increase (Decrease) in Stockholders' Equity          
Exercise of stock options   6     $ 6
Exercise of stock options (in shares) 3,997        
Exercise of warrants   150     150
Exercise of warrants (in shares) 32,573        
Repurchase of common stock   (8,955)     (8,955)
Repurchase of common stock (in shares) (2,456,141)        
Vesting of restricted stock awards and units (in shares) 3,334,571        
Vesting of performance-based stock units (in shares) 423,677        
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations   (4,357)     (4,357)
Shares of restricted stock returned to the Company under net share settlements to satisfy tax withholding obligations (in shares) (1,161,853)        
Stock-based compensation expense   19,406     19,406
Other comprehensive loss       (1,513) (1,513)
Net income (loss)     39,636   39,636
Ending balance at Dec. 31, 2025 $ 18 $ 1,976,958 $ (1,534,549) $ 6,567 $ 448,994
Ending balance (in shares) at Dec. 31, 2025 175,776,074       175,776,074